-2.85%
Today
Loading 1D prices…
Company profile
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Sector
Health Care
Industry
Electromedical & Electrotherapeutic Apparatus
Exchange
Nasdaq
Display currency
USD
Location
Ann Arbor, MI, United States
Employees
9
Fiscal year end
1231
CIK
1681682
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ITOCiTonic Holdings Ltd Class A Ordinary Shares | $7.5M | $523K | -974.68% | -$0.318 | -0.92% | Unrated |
| IRIXIRIDEX Corporation Common Stock | $11.6M | $52.7M | -8.42% | -$0.26 | -2.94% | Unrated |
| NXLNexalin Technology Inc. Common Stock | $4M | $301.6K | -2725.76% | -$0.50 | -1.03% | Buy |
| NUWENuwellis Inc. Common Stock | $2.5M | $8.3M | -211.86% | -$25.39 | 0.00% | Unrated |
| QTIQT Imaging Holdings Inc. Common Stock | $38.6M | $18.9M | -111.40% | -$2.01 | +1.54% | Buy |